SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-178143
Filing Date
2019-06-21
Accepted
2019-06-21 08:06:56
Documents
5
Period of Report
2019-06-21
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d765696d8k.htm 8-K 19234
2 EX-99.1 d765696dex991.htm EX-99.1 21799
3 EX-99.2 d765696dex992.htm EX-99.2 18969
4 GRAPHIC g765696g0621044428208.jpg GRAPHIC 2952
5 GRAPHIC g765696g0621072056373.jpg GRAPHIC 2952
  Complete submission text file 0001193125-19-178143.txt   69593
Mailing Address ONE NEWTON EXECUTIVE PARK SUITE 202 NEWTON MA 02462
Business Address ONE NEWTON EXECUTIVE PARK SUITE 202 NEWTON MA 02462 617-467-4577
Allena Pharmaceuticals, Inc. (Filer) CIK: 0001624658 (see all company filings)

IRS No.: 452729920 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38268 | Film No.: 19909847
SIC: 2836 Biological Products, (No Diagnostic Substances)